Activation of ERK and Akt signaling in focal cerebral ischemia: Modulation by TGF-α and involvement of NMDA receptor

Neurobiology of Disease

Volumn 11, Issue 3, 2002, Pages 443-456

  Friguls, Bibiana ^a,b   Petegnief, Valérie ^a   Justicia, Carles ^a   Pallàs, Mercè ^b   Planas, Anna M ^a,c  

^a INST D INVESTIGACIONS B   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0037000035     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0553     Document Type: Article

References (64)

1. Ahmed N. N., Grimes H. L., Bellacosa A., Chan T. O., Tsichlis P. N. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:1997;3627-3632.
2. Alessandrini A., Namura S., Moskowitz M. A., Bonventre J. V. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA. 96:1999;12866-12869.
3. Bading H., Greenberg M. E. Stimulation of protein tyrosine phosphorylation by NMDA receptor activation. Science. 253:1991;912-914.
4. Bogoyevitch M. A., Gillespie-Brown J., Ketterman A. J., Fuller S. J., Ben-Levy R., Ashworth A., Marshall C. J., Sugden P. H. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. P38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ. Res. 79:1996;162-173.
5. Bonni A., Brunet A., West A. E., Datta S. R., Takasu M. A., Greenberg M. E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1999;1358-1362.
6. Bosser R., Faura M., Serratosa J., Renau-Piqueras J., Pruschy M., Bachs O. Phosphorylation of rat liver heterogeneous nuclear ribonucleoproteins A2 and C can be modulated by calmodulin. Mol. Cell. Biol. 15:1995;661-670.
7. Cattaneo E., Pelicci P. G. Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain. Trends Neurosci. 21:1998;476-481.
8. Chalecka-Franaszek E., Chuang D.-M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. USA. 96:1999;8745-8750.
9. Chandler L. J., Sutton G., Dorairaj N. R., Norwood D. N-Methyl D-Aspartate receptor-mediated bi-directional control of extracellular signal-regulated kinase activity in cortical neuronal cultures. J. Biol. Chem. 276:2001;2627-2636.
10. Datta S. R., Dudeck H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
11. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., Greenberg M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-665.
12. Ferrer I., Alcántara S., Ballabriga J., Olivé M., Blanco R., Rivera R., Carmona M., Berruezo M., Pitarch S., Planas A. M. Transforming growth factor-α (TGF-α) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain. Prog. Brain Res. 49:1996;99-123.
13. Friguls B., Justicia C., Pallàs M., Planas A. M. Focal cerebral ischemia causes two temporal waves of Akt activation. NeuroReport. 12:2001;3381-3384.
14. Fukunaga K., Miyamoto E. Role of MAP kinase in neurons. Mol. Neurobiol. 16:1998;79-95.
15. Fuller G., Veitch K., Ho L. K., Cruise L., Morris B. J. Activation of p44/p42 MAP kinase in striatal neurons via kainite receptors and PI3 kinase. Mol. Brain Res. 89:2001;126-132.
16. Gelb A. W., Zhang C., Hamilton J. T. In vitro cerebral vasoactive effects of MK-801. J. Neurosurg. Anesthesiol. 7:1995;262-270.
17. Gómez-Pinilla F., Knauer D. J., Nieto-Sampedro M. Epidermal growth factor receptor immu-noreactivity in the rat brain: Developmental and cellular localization. Brain Res. 438:1988;385-390.
18. Han B. H., Holtzman D. M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20:2000;5755-5781.
19. Hardingham G. E., Arnold F. J. L., Bading H. A calcium microdomain near NMDA receptors: On switch for ERK-dependent synapse-to-nucleus communication. Nature Neurosci. 4:2001;565-566.
20. Hetman M., Kanning K., Cavanaugh J. E., Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular -signal-regulated kinase and phosphatidylinositol-3 kinase. J. Biol. Chem. 274:1999;22569-22580.
21. Irving E. A., Barone F. C., Reith A. D., Hadingham S. J., Parsons A. A:. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat. Mol. Brain Res. 77:2000;65-75.
22. Jiang Q., Gu Z., Zhang G., Jing G. N-Methyl-D-aspartate receptor activation results in regulation of extracellular signal-regulated kinases by protein kinases and phosphatases in glutamate-induced neuronal apoptotic-like death. Brain Res. 887:2000;285-292.
23. Junier M. What roles for TGFα in the central nervous system? Prog. Neurobiol. 62:2000;443-473.
24. Justicia C., Pérez-Asensio F. J., Burguete M. C., Salom J. B., Planas A. M. Administration of Transforming Growth Factor-α reduces infarct volume after transient focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 21:2001;1097-1104.
25. Justicia C., Planas A. M. Transforming Growth Factor-α acting at the Epidermal Growth Factor Receptor reduces infarct volume after permanent middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 19:1999;128-132.
26. Katsuta K., Nakanishi H., Shirakawa K., Yoshida K., Takagi K., Tamura A. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15:1995;345-348.
27. Kauffmann-Zeh A., Rodríguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385:1997;544-548.
28. Koulich E., Nguyen T., Johnson K., Giardina C. A., D'Mello S. R. NF-κB is involved in the survival of cerebellar granule neurons: Association of IκB phosphorylation with cell survival. J. Neurochem. 76:2001;1188-1198.
29. Krizbai I. A., Bauer H., Amberger A., Henni B., Szabo H., Fuchs R., Bauer H. C. Growth factor-induced morphological, physiological and molecular characteristics in cerebral endothelial cells. Eur. J. Cell Biol. 79:2000;594-600.
30. Kulich S. M., Chu C. T. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: Implications for Parkinson's disease. J. Neurochem. 77:2001;1058-1066.
31. Luo Y., Bond J. D., Ingram V. M. Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. Proc. Natl. Acad. Sci. USA. 94:1997;9705-9710.
32. Matsuoka Y., Kitamura Y., Okazaki M., Terai K., Taniguchi T. Kainic acid-induced activation of nuclear factor-κB in rat hippocampus. Exp Brain Res. 124:1999;215-222.
33. Nieto-Sampedro M., Gómez-Pinilla F., Knauer D. J., Broderick J. T. Epidermal growth factor receptor immunoreactivity in rat brain astrocytes: Response to injury. Neurosci. Lett. 91:1988;276-282.
34. Nishida E., Gotoh Y. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends. Biochem. Sci. 18:1993;128-131.
35. Noshita N., Lewen A., Sugawara T., Chan P. H. Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 21:2001;1442-1450.
36. Okano J.-i., Gaslightwala I., Birnbaum M. J., Rustgi A. K., Nakagawa H. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275:2000;30934-30942.
37. Pagès G., Stanley E. R., Le Gall M., Brunet A., Pouysségur J. The mouse p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1) gene. J. Biol. Chem. 270:1995;26986-26992.
38. Park C. K., Nehls D. G., Graham D. I., Teasdale G. M., McCulloch J. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24:1988;543-551.
39. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, New York.
40. Peng H., Wn T.-C., Tanaka J., Maeda N., Matsuda S., Desaki J., Sudo S., Zhang B., Sakanaka M. Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries. J. Cereb. Blood Flow Metab. 18:1998;349-360.
41. Planas A. M, Justicia C., Soriano M. A., Ferrer I. Epidermal growth factor receptor in proliferating reactive glia following transient focal ischemia in the rat brain. Glia. 23:1998;120-129.
42. Ramoa A. S., Alkondon M., Aracava Y., Irons J., Lunt G. G., Deshpande S. S., Wonnacott S., Aronstam R. S., Albuquerque E. X. The anticonvulsant MK-801 interacts with peripheral and central nicotine acetylcholine receptor ion channels. J. Pharmacol. Exp. Ther. 254:1990;71-82.
43. Rosen L. B., Ginty D. D., Weber M. J., Greenberg M. E. Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras. Neuron. 12:1994;1207-1221.
44. Schlessinger J., Ullrich A. Growth factor signalling by receptor tyrosine kinases. Neuron. 9:1992;383-391.
45. Schwarzschild M. A., Cole R. L., Meyers M. A., Hyman S. E. Contrasting calcium dependencies of SAPK and ERK activations by glutamate in cultured striatal neurons. J. Neurochem. 72:1999;2248-2255.
46. Seger R., Krebs E. G. The MAPK signalling cascade. FASEB J. 9:1995;726-735.
47. Slevin M., Krupinski J., Slowik A., Rubio F., Szczudlik A., Gaffney J. Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. NeuroReport. 11:2000;2759-2764.
48. Songyang Z., Baltimore D., Cantley L. C., Kaplan D. R., Franke T. F. Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:1997;11345-11350.
49. Stanciu M., DeFranco D. B. Prolonged nuclear retention of extracellular signal-regulated protein kinase promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line. J. Biol. Chem. 277:2002;4010-4017.
50. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M. R., Johnson J. W., DeFranco D. B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275:2000;12200-12206.
51. Sweatt J. D. The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76:2001;1-10.
52. Thompson R. J. Studies on RNA synthesis in two populations of nuclei from the mammalian cerebral cortex. J. Neurochem. 21:1973;19-40.
53. Torregrosa G., Salom J. B., Jover T., Alabadi J. A., Miranda F. J., Alborch E. Evidence of a direct constrictor action of MK-801 and its modulation by the endothelium in cerebral arteries. J. Vasc. Res. 31:1994;221-229.
54. Travis M. D., Lewis S. J. Apparent association of MK-801-sensitive ion channels with L-S-nitrosocysteine recognition sites in the hindlimb vasculature of the rat. Eur. J. Pharmacol. 407:2000;309-312.
55. Treisman R. Ternary complex factors: Growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:1994;96-101.
56. van der Geer P., Wiley S., Lai V. K., Olivier J. P., Gish G. D., Stephens R., Kaplan D., Shoelson S., Pawson T. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr. Biol. 5:1995;404-412.
57. Wang X., McCullough K. D., Franke T. F., Holbrook N. J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275:2000;14624-14631.
58. Vendrell M., Aligué R., Bachs O., Serratosa J. Presence of calmodulin and calmodulin-binding proteins in the nuclei of brain cells. J. Neurochem. 57:1991;622-628.
59. Wu D.-C., Ye W., Che X.-M., Yang G.-Y. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J. Cereb. Blood Flow Metab. 20:2000;1320-1330.
60. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
61. Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B., Korsmeyer S. J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
62. Yamada M., Ikeuchi T., Hatanaka H. The neurotrophic action and signalling of epidermal growth factor. Prog. Neurobiol. 51:1997;19-37.
63. Zelenaia O., Schlag B. D., Gochenauer G. E., Ganael R., Song W., Beesley J. S., Grinspan J. I., Rothstein J. D., Robinson M. B. Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-κB. Mol. Pharmacol. 57:2000;667-678.
64. Zwick E., Daub H., Aoki N., Yamaguci-Aoki Y., Tinhofer I., Maly K., Ullrich A. Critical role of calcium-dependent epidermal growth factor receptor transctivation in PC12 cell membrane depolarization and bradykinin signalling. J. Biol. Chem. 272:1997;24767-24770.